Pharma News Briefs

• Novartis announced last week that European regulators have approved its follow-on biologic epoetin alfa, which is biosimilar to J&J's Eprex.  Pharmalot posted this story today about J&J's reaction.
• The WSJ Health Blog had this interesting post last week reporting that more clinical trials are now under way in China than in India.
• Adams Respiratory Therapeutics is facing a patent challenge by Perrigo over its Mucinex cough medicine.  Bloomberg recently published this report; MarketWatch.com had this one.
• The Wall St. Journal published this interesting article (subscription) a couple weeks ago about a drug development partnership between Eli Lilly and Chi-Med, a Chinese biotechnology company.
• FDA Law Blog had this post last month about impending FDA enforcement action on marketed unapproved drugs.
• Finally, a couple oldies but goodies from Pharma's Cutting Edge: Ariad v. Lilly patent litigation; response to Richard Epstein's Overdose.